iPSC-derived Photoreceptor Progenitor Cells With Media

Description

Take advantage of 25% off on these iPSC-derived Cells with Media – offer ends December 31, 2025

Applied StemCell has developed an efficient integration-free, small molecule-based method to differentiate high-quality retinal pigment epithelium (RPE) precursor cells from human iPSCs. The differentiated RPE cells recapitulate the phenotype and functional parameters of primary and in vivo RPE cells.

We provide RPE cells differentiated from an integration-free, control human iPSC line (ASE-9211), reprogrammed from fibroblasts of an African American male donor. These cryopreserved, high-purity (>90%) cells express high levels of RPE biomarkers PMEL1, MITF, ZO-1, and RPE65.

These iPSC-differentiated RPE cells can be used as control lines to compare the phenotype and functionality of patient-derived, genome-edited iPSC-derived RPE cells for drug screening applications.

To harness the full potential of our photoreceptor cells, this product contains an optimized Photoreceptor Maturation Basal Medium and a Photoreceptor Culture Maturation Media Supplement, both formulated to support robust maintenance and functionality of the cells in culture.

• SUPPLIER:

  Applied StemCell

• STATUS:

  In Stock

• SIZE:

  kit